期刊文献+

2型糖尿病患者并发肾脏疾病影响因素的Meta分析 被引量:19

Influencing Factors for Type 2 Diabetic Kidney Disease: A Meta-analysis
下载PDF
导出
摘要 目的系统评价2型糖尿病患者并发肾脏疾病的影响因素。方法计算机检索美国国立医学图书馆(MEDLINE,1960.01—2012.12)、EMBase(1980.01—2012.12)、中国生物医学文献服务系统(CBM,1969.01—2012.12)、中国期刊全文数据库(CNKI,1981.01—2012.12)、中国科技期刊数据库(VIP,1989.01—2012.12)及万方数据资源系统(1998.01—2012.12)的相关文献。采用Rev Man 5.2统计软件对纳入文献进行Meta分析,探讨2型糖尿病患者并发肾脏疾病的影响因素。结果共纳入文献7篇,其中6篇为横断面研究,1篇为病例对照研究,总样本量为3 548例。Meta分析结果 :(1)病例对照研究的单因素分析显示,年龄对2型糖尿病患者并发肾脏疾病的影响有统计学意义,合并MD值为2.37〔95%CI(0.20,4.54)〕;横断面研究的单因素分析显示,年龄对2型糖尿病患者并发肾脏疾病的影响有统计学意义,合并MD值为5.61〔95%CI(1.54,9.68)〕。横断面研究的多因素分析显示,年龄对2型糖尿病患者并发肾脏疾病的影响有统计学意义,合并OR值为1.02〔95%CI(1.01,1.03)〕。(2)横断面研究的单因素分析显示,性别对2型糖尿病患者并发肾脏疾病的影响有统计学意义,合并OR值为1.28〔95%CI(1.03,1.58)〕。横断面研究的多因素分析显示,性别对糖尿病患者并发肾脏疾病的影响有统计学意义,合并OR值为0.46〔95%CI(0.22,0.95)〕。(3)病例对照研究的单因素分析显示,文化程度、婚姻状况及家庭经济收入对2型糖尿病患者并发肾脏疾病的影响无统计学意义,合并OR值分别为0.54〔95%CI(0.24,1.24)〕、1.77〔95%CI(0.92,3.41)〕及0.74〔95%CI(0.44,1.24)〕。(4)病例对照研究的单因素分析显示,自我效能分级(高等水平/低等水平)和症状管理自我效能分级(高等水平/低等水平)对2型糖尿病患者并发肾脏疾病的影响有统计学意义,合并OR值分别为0.24〔95%CI(0.10,0.60)〕和0.29〔95%CI(0.10,0.83)〕;多因素分析显示,自我效能(高等水平/低等水平)和自我效能(中等水平/低等水平)对2型糖尿病患者并发肾脏疾病的影响有统计学意义,合并OR值分别为0.30〔95%CI(0.11,0.87)〕和0.18〔95%CI(0.06,0.52)〕。结论社会人口学因素中的年龄、性别及心理因素中的自我效能,是2型糖尿病患者并发肾脏疾病的影响因素。 Objective To systematically review the influencing factors for type 2 diabetic kidney disease ( DKD) . Methods We made computer -based retrieval from MEDLINE (1960.01—2012.12), EMBase (1980.01—2012.12), CBM ( 1969.01—2012.12 ) , CNKI ( 1981.01—2012.12 ) , VIP ( 1989.01—2012.12 ) and Wanfang database ( 1998.01—2012.12) .RevMan 5.2 statistic software was used to conduct meta -analysis and investigate the influencing factors for type 2 diabetic kidney disease.Results We included 7 pieces of literature , among which 6 pieces were of cross -sectional study and one case was of case -control study.There were all together 3 548 subjects involved in the study .The results showed by the meta-analysis were as follows.(1) The univariate analyses of case -control study showed that age had influence on the occurrence of type 2 diabetic kidney disease , with a combining MD value of 2.37 〔95%CI (0.20, 4.54)〕; the univariate analyses of cross-sectional study showed that age had influence on the occurrence of type 2 diabetic kidney disease , with a combining MD value of 5.61 〔95%CI (1.54, 9.68)〕 .The multivariate analyses of cross -sectional research showed that age had influence on the occurrence of type 2 diabetic kidney disease , with a combining MD value of 1.02 〔95%CI (1.01, 1.03)〕 .(2) The univariate analyses of cross -sectional study showed that gender had influence on type 2 diabetic kidney disease , with a combining OR value of 1.28 〔95%CI ( 1.03, 1.58 )〕 .The multivariate analyses of cross -sectional research showed that gender had influence on type 2 diabetic kidney disease , with a combining OR value of 0.46 〔95%CI (0.22, 0.95)〕 .(3) The univariate analyses of case -control study showed that education level , marital status and the total income of a household had no influence on type 2 diabetic kidney disease , with combining OR values of 0.54 〔95%CI (0.24, 1.24)〕, 1.77 〔95%CI (0.92, 3.41)〕 and 0.74 〔95%CI (0.44, 1.24)〕 respectively.(4) The univariate analyses of case -control study showed that self-efficacy ( high level/low level ) and self -efficacy of symptom management ( high level/low level ) had influence on type 2 diabetic kidney disease , with combining OR values of 0.24 〔95%CI ( 0.10, 0.60 )〕 and 0.29 〔95%CI ( 0.10, 0.83)〕; multivariate analyses showed that self -efficacy ( high level/low level ) and self -efficacy ( intermediate level/low level) had influence on type 2 diabetic kidney disease , with combining OR values of 0.30 〔95%CI (0.11, 0.87)〕 and 0.18〔95%CI (0.06, 0.52)〕 respectively.Gonclusion Age, gender and self -efficacy are influencing factors for the occurrence of type 2 diabetic kidney disease .
出处 《中国全科医学》 CAS CSCD 北大核心 2015年第22期2732-2736,共5页 Chinese General Practice
关键词 糖尿病 2型 糖尿病肾病 影响因素分析 META分析 Diabetic nephropathies Root cause analysis Meta-analysis
  • 相关文献

参考文献22

  • 1Gowdak LH, Arantes RL, de Paula FJ, et al. Underuse of American College of Cardiology/American Heart Association Guidelines in hemodialysis patients [J]. Ren Fail, 2007, 29 (5): 559-565.
  • 2Keane WF, Zhang Z, Lyle PA, et al. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study [J]. Clin J Am Soc Nephml, 2006, 1 (4) : 761 - 767.
  • 3Stenvinkel P. Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease [ J ]. J Intern Med, 2010, 268 (5): 456-467.
  • 4Reutens AT, Atkins RC. Epidcmiology of diabetic nephropathy [ J ]. Contrib Nephrol, 2011, 170: 1-7.
  • 5Tang SC. Diabetic nephropathy: a global and growing threat [ J ]. Hong Kong Med J, 2010, 16 (4) : 244 -245.
  • 6WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications [ Z ] . Geneva: WHO, 1999.
  • 7Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus [ J ]. Diabetes Care, 2003, 26 (1) : s5 -20.
  • 8American Diabetes Association. Diagnosis and classification of diabetes mellitus [J]. Diabetes Care , 2012, 35 (1): 64-71.
  • 9American Diabetes Association. Standards of medical care in diabetes [J]. Diabetes Care, 2011, 34 (1): 11-61.
  • 10National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification [J]. Am J Kidney Dis, 2002, 39 (2 suppl 1) : 1 -266.

二级参考文献40

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3046
  • 2杜宏,唐政,陈惠萍,赵明.2型糖尿病肾病患者肾脏预后因素分析[J].中国医师杂志,2006,8(5):652-653. 被引量:5
  • 3谌贻璞.代谢综合征肾损害:已知与未知[J].中华肾脏病杂志,2006,22(7):381-382. 被引量:12
  • 4Strazzullo P, Barbato A, Siani A. et al. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population [J]. Metabolism, 2008, 57(3): 355-361.
  • 5Zarich SW. Metabolic syndrome, diabetes and cardiovascular events:current controversies and recommendations [J]. Minerva Cardioangiol, 2006, 54(2): 195-214.
  • 6Schelling JR, Sedor JR. The metabolic syndrome as a risk factor for chronic kidney disease, more than a fat chance? [J]. J Am Soc Nephrol, 2004, 15 ( 11 ) : 2773-2774.
  • 7American Diabetes Association. Diagnosis and classification of diabetes mellitus [J]. Diabetes Care, 2005, 28(Suppl 1):37-42.
  • 8Kopple JD. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure [J]. Am J Kidney Dis, 2001, 37 (1 Suppl 2):66-70.
  • 9Chen J, Muntner Po Hamm LL, et al. The metabolic syndrome and chronic kidney disease in US adults [J]. Ann Intern Med, 2004, 140(3): 167-174.
  • 10Ninomiya T, Kiyohara Y, Kubo M, et al. Metabolic Syndrome and CKD in a General Japanese Population:The Hisayama Study [J]. Am J Kidney Dis, 2006, 48(3) : 383-391.

共引文献26

同被引文献143

引证文献19

二级引证文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部